Format
Items per page
Sort by

Send to:

Choose Destination

Results: 19

Related Articles by Review for PubMed (Select 17327458)

1.

Polymorphisms of the renin-angiotensin system genes predict progression of subclinical coronary atherosclerosis.

Kretowski A, McFann K, Hokanson JE, Maahs D, Kinney G, Snell-Bergeon JK, Wadwa RP, Eckel RH, Ogden L, Garg S, Li J, Cheng S, Erlich HA, Rewers M.

Diabetes. 2007 Mar;56(3):863-71.

2.
3.
4.

Angiotensin converting enzyme insertion/deletion polymorphism and renoprotection in diabetic and nondiabetic nephropathies.

Ruggenenti P, Bettinaglio P, Pinares F, Remuzzi G.

Clin J Am Soc Nephrol. 2008 Sep;3(5):1511-25. doi: 10.2215/CJN.04140907. Epub 2008 Jun 11. Review.

5.

Pharmacogenomics of renin angiotensin system inhibitors in coronary artery disease.

Tsikouris JP, Peeters MJ.

Cardiovasc Drugs Ther. 2007 Apr;21(2):121-32. Review.

PMID:
17486303
6.

[The role of genetic studies in finding the etiopathogenesis of diabetes mellitus].

Sieradzki J.

Przegl Lek. 2000;57 Suppl 3:3-6. Review. Polish.

PMID:
11293231
7.

[Polymorphic markers of vasoactive hormones genes and progression of renal diseases].

Kamyshova ES, Nosikov VV, Kutyrina IM.

Ter Arkh. 2003;75(6):79-84. Review. Russian. No abstract available.

PMID:
12920967
8.

The impact of renin-angiotensin system polymorphisms on physiological and pathophysiological processes in humans.

Miller JA, Scholey JW.

Curr Opin Nephrol Hypertens. 2004 Jan;13(1):101-6. Review.

PMID:
15090866
9.

[Renin-angiotensin system: molecular biology].

Zidzik J, Salagovic J, Fleischer B, Kalina I.

Cesk Fysiol. 2004;53(4):142-51. Review. Slovak.

PMID:
15704738
10.

The renin angiotensin system as a risk factor for coronary artery disease.

Farmer JA, Torre-Amione G.

Curr Atheroscler Rep. 2001 Mar;3(2):117-24. Review.

PMID:
11177655
11.

[Plasminogen activator inhibitor-1 (PAI-1), ischemic heart disease and diabetes mellitus].

Olexa P, Olexová M.

Vnitr Lek. 2003 Mar;49(3):222-6. Review. Slovak.

PMID:
12728597
12.

[Genetics of cardio-vascular complications of diabetes].

Soubrier F.

Ann Endocrinol (Paris). 1996;57(3):155-9. Review. French.

PMID:
8949409
13.

[Genetic predisposition to cardiovascular diseases].

Stajszczyk M, Gmiński J.

Przegl Lek. 2000;57(1):48-51. Review. Polish.

PMID:
10907371
14.

Clinical trials: surrogate endpoints or hard endpoints?

Kuller LH.

Am J Cardiol. 2001 Jul 19;88(2A):59E-61E. Review.

PMID:
11473750
15.

Essential hypertension in women.

Os I, Oparil S, Gerdts E, Høieggen A.

Blood Press. 2004;13(5):272-8. Review. No abstract available.

PMID:
15545149
16.

Polymorphisms in the genes of the renin system and progression of renal disease: a critical review.

Zoccali C, Testa A, Spoto B.

Adv Nephrol Necker Hosp. 2001;31:105-17. Review. No abstract available.

PMID:
11692453
17.

Type 1 diabetes and coronary artery disease.

Orchard TJ, Costacou T, Kretowski A, Nesto RW.

Diabetes Care. 2006 Nov;29(11):2528-38. Review. No abstract available.

PMID:
17065698
18.

Coronary calcification and hormones.

Koulaouzidis G, Henein M.

Angiology. 2011 Oct;62(7):554-64. doi: 10.1177/0003319711399418. Epub 2011 Mar 18. Review.

PMID:
21421627
19.

Leukotrienes and atherosclerosis.

Khan Z, Tripathi CD.

Indian Heart J. 2005 Mar-Apr;57(2):175-80. Review. No abstract available.

PMID:
16013362
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk